AMRX PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

AMRX ▲ +5.51% at T+20d

NEUTRAL call ✓ call won +5.51% · α vs SPY -3.04% · entry $12.71 → $13.41

Next anchor: T+60d in 19d

Currently $16.20 · +27.46% from $12.71 entry

Entry anchored
Apr 7, 03:59 PM ET
via Databento tick

T+1d

+0.71%

call +0.71% · α +0.13%

$12.80

settled 2mo ago

T+5d

+2.68%

call +2.68% · α -0.84%

$13.05

settled 2mo ago

T+20d

+5.51%

call +5.51% · α -3.04%

$13.41

settled 6w ago

T+60d

—

call — · α —

—

in 19d

Price Chart

Loading chart...

Executive Summary

Amneal Pharmaceuticals announced it will release Q1 2026 financial results on May 1, 2026, with no updated financials provided in this press release. The prior quarter (Q4 2025) reported EPS of $0.21, a 28% beat versus consensus of $0.16, and revenue of $715.2M, though no surprise is indicated for revenue.

Actionable Insight

Traders should monitor the upcoming Q1 2026 earnings call for potential guidance updates or commentary on margins and segment performance, particularly in Specialty and Biosimilars. No immediate trading catalyst in this release.

Key Facts

Amneal announced the date for its Q1 2026 earnings release: May 1, 2026, before market open.
No new financial results were disclosed in this press release.
Q4 2025 results: EPS of $0.21 (28% beat vs. $0.16 estimate), revenue of $715.2M in line with estimates.
Company will host a webcast and conference call on May 1, 2026, at 8:30 a.m. ET.

Financial Impact

No new financial impact disclosed; prior quarter showed strong EPS beat.

epsrevenue

Risk Factors

Lack of updated financials or guidance in this release limits immediate trading relevance.
Potential for muted market reaction due to absence of new data.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3269613

6 reports for AMRX

T+1T+5T+20T+60

33% Hit rate 1 of 3 directional calls best @ T+20▲ +4.17%May 7, 2026

Filters

Reports for AMRX — sortable, filterable
	Type				Now
Jun 11, 2026 1d ago	Institutional Cluster MIXED ★ 4/10	$15.72 awaiting T+20	awaiting T+20	—	$16.20 (+3.05%)
May 7, 2026 5w ago	Press Release BULLISH ★ 8/10	$13.20 $13.75	▲ +4.17%	▲ +4.14%	$16.20 (+22.73%)
Apr 22, 2026 7w ago	Press Release BULLISH ★ 9/10	$12.82 $11.81	▼ −7.88%	▼ −11.04%	$16.20 (+26.37%)
Apr 7, 2026 9w ago	Press Release NEUTRAL ★ 3/10	$12.71 $13.41	▲ +5.51%	▼ −3.04%	$16.20 (+27.46%)
Mar 25, 2026 11w ago	DEFA14A NEUTRAL ★ 3/10	$12.06 $12.52	▲ +3.81%	▼ −6.85%	$16.20 (+34.33%)
Feb 27, 2026 15w ago	8-K BULLISH ★ 8/10	$13.81 $11.85	▼ −14.19%	▼ −6.64%	$16.20 (+17.31%)

US Market Status

Market Closed — Opens Mon (49h 14m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access